Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ebdarokimab is a fully human monoclonal antibody (mAb) designed to inhibit the IL-12/IL-23 pathway through its highly specific binding to the shared p40 subunit common to both interleukin-12 and interleukin-23 cytokines, resulting in the potent inhibition of their downstream signaling cascades. Ebdarokimab can be used in studies about systemic lupus erythematosus (SLE) and severe plaque psoriasis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $332 | In Stock | |
5 mg | $996 | In Stock | |
10 mg | $1,570 | In Stock |
Description | Ebdarokimab is a fully human monoclonal antibody (mAb) designed to inhibit the IL-12/IL-23 pathway through its highly specific binding to the shared p40 subunit common to both interleukin-12 and interleukin-23 cytokines, resulting in the potent inhibition of their downstream signaling cascades. Ebdarokimab can be used in studies about systemic lupus erythematosus (SLE) and severe plaque psoriasis. |
Cas No. | 2393651-11-9 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.